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Purpose: Successful endovascular repair of an abdominal aortic aneurysm (AAA) requires
the creation of a hemostatic seal between the endograft and the underlying aortic wall.
A short infrarenal aortic neck may be responsible for incomplete aneurysm exclusion and
procedural failure. Sixteen patients who had an endograft positioned completely below
the lowest renal artery and 37 patients in whom a porous portion of an endograft
attachment system was deliberately placed across the renal arteries were studied to iden-
tify if endograft positioning could impact on the occurrence of incomplete aneurysm
exclusion. 
Methods: Fifty-three patients underwent aortic grafting constructed from a Palmaz bal-
loon expandable stent and an expandable polytetrafluoroethylene (ePTFE) graft
implanted in an aorto-ilio-femoral, femoral-femoral configuration. Arteriography,
duplex ultrasonography and spiral CT scans were performed in each patient before and
after endografting to evaluate for technical success, the presence of endoleaks, and renal
artery perfusion. 
Results: There was no statistically significant difference in patient demography, AAA size,
or aortic neck length or diameter between patients who had their endografts placed
below or across the renal arteries. However, significantly more proximal aortic endoleaks
occurred in those patients with infrarenal endografts (P ≤ .05). Median serum creati-
nine level before and after endografting was not significantly different between the 2
patient subgroups, with the exception of 2 patients who had inadvertent coverage of a
single renal orifice by the endograft. Median blood pressure and the requirement for
antihypertensive therapy remained the same after transrenal aortic stent grafting.
Significant renal artery compromise did not occur after appropriately positioned tran-
srenal stents as shown by means of angiography, CT scanning, and duplex ultrasound
scan. Mean follow-up time was 10.3 months (range, 3 to 18 months). Patients who had
significant renal artery stenosis (‡ 50%) before aortic endografting did not show pro-
gression of renal artery stenosis after trans-renal endografting. Two patients with trans-
renal aortic stent grafts had inadvertent coverage of 1 renal artery by the endograft
because of device malpositioning, which resulted in nondialysis dependent renal insuffi-
ciency. In addition, evidence of segmental renal artery infarction (<20% of the kidney),
which did not result in an apparent change in renal function, was shown by means of
follow-up CT scans in 2 patients with transrenal endografts.
Conclusion: Transrenal aortic endograft fixation using a balloon expandable device in
patients with AAAs can result in a significant reduction in the risk of proximal
endoleaks. Absolute attention to precise device positioning, coupled with the use of
detailed imaging techniques, should reduce the risk of inadvertent renal artery occlusion
from malpositioning. Long-term follow-up is essential to determine if there will be late
sequelae of transrenal fixation of endografts, which could adversely effect renal perfu-
sion. (J Vasc Surg 1998;28:638-46.)
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Endovascular repair of abdominal aortic aneurysms
(AAAs) is a rapidly evolving technique that continues
to undergo both procedural and device-related modi-
fications. It was initially apparent to Parodi et al1 that
few infrarenal aneurysms would be amenable to simple
endovascular repairs using isolated proximal infrarenal
fixation and distal aortic cuff attachment. Although
approximately 85% of aortic aneurysms are in the
infrarenal position, on close inspection many of these
lesions show insufficient normal aorta immediately
below the renal vessels to provide for secure, long-
term attachment of an aortic endograft.2,3 In 1990,
Parodi inserted an endograft with the porous portion
of a balloon expandable stent attachment system
across the orifices of the renal arteries permitting con-
tinued kidney perfusion and successful aortic
aneurysm exclusion in a patient who had a short
infrarenal neck (J.C. Parodi, personal communica-
tions, 1990). The feasibility of transrenal endograft
attachment and the potential impact on renal perfu-
sion in animal models have been further shown by
subsequent laboratory investigations.4-11 Early clinical
studies have confirmed these findings.12-14 A single
experience with transrenal endograft attachment for
repair of AAA with a Palmaz balloon expandable sys-
tem in medically high risk patients was analyzed.
METHODS
Patient selection. Endovascular repair of AAAs
was carried out in accordance with an investigator-
sponsored Investigational Device Exemptions from
the Food and Drug Administration (FDA), with
approval of the Mount Sinai Medical Center
Institutional Review Board and informed patient con-
sent. Patients selected for this trial had infrarenal
aneurysms 5 cm or larger and significant medical
comorbidities that put them at high risk for major
complications or death from conventional aortic
repair. Each prospective patient was screened by 2
independent nonsurgical medical specialists who were
charged with evaluating surgical risk. Standard criteria,
as outlined by Goldman et al15 and Freeman et al,16
were applied to risk determination decisions. Those
patients who were felt to be at a 20% or greater risk of
a major complication or death from conventional
repair were offered endovascular aortic reconstruction.
For preprocedural planning, each patient
received an angiogram and a spiral CT scan before
endovascular abdominal aneurysm repair. The
length of the proximal aortic neck was defined as the
distance from the inferior margin of the lowest renal
artery to the proximal portion of the aneurysm.
Endovascular aortic device. All AAA repairs
were performed using a balloon expandable system
similar in design to the device described by Parodi et
al.17 The transrenal attachment system was created
from a Palmaz balloon expandable stent (p5014,
Cordis Endovascular, Johnson & Johnson, Warren,
NJ) and a 28 to 8 mm tapered expanded polytetra-
fluoroethylene (ePTFE) graft (8 mm thin-walled
graft, Impra, Tempe, AZ) (Fig 1). At an example
expansion of 26 mm, the fenestrated portions of the
stent measured 6.3 · 6.0 mm, with a stent thickness
of 0.3 mm (Fig 2).
Each stent was fixed to a tapered ePTFE graft by
means of 4 ePTFE sutures (CV 5, W.L. Gore and
Fig 1. Balloon expandable polytetrafluoroethylene endo-
graft for repair of an abdominal aortic aneurysm. A tapered
(28 mm to 8 mm) expanded polytetrafluoroethylene graft is
used for aortic reconstruction. A Palmaz balloon expand-
able stent is sutured to the proximal end of the graft (arrow)
so 2 cm of stent is exposed and uncovered by the overlying
prosthesis. A gold marker (open arrow) is affixed to the mar-
gin of the graft to facilitate radiographic localization.
Fig 2. Palmaz balloon expandable stent—deployed. A
large Palmaz balloon expandable stent in the deployed
state (26 mm) contains diamond configured spaces that
measure on average 6.3 · 6.0 mm (arrows).
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Associates, Flagstaff, Ariz). When the endograft was
deployed to 26 mm, 20 mm of uncovered stent pro-
jected from the undeployed device; expected fore-
shortening of the stent resulted in 12 mm of bare
stent for transrenal fixation. The total transrenal seg-
ment varied between 11 and 13 mm. For precise
positioning, a gold marker was placed at the inter-
face between the graft and the underlying stent to
mark the site where the graft begins. Each endovas-
cular graft was coaxially attached to a customized
balloon catheter delivery system and gas sterilized
before use (Fig 3).
Technique for endovascular graft insertion.
Each patient underwent aortography and spiral CT
scanning before endovascular repair of the AAA.
In the initial phase of this study (group 1), endo-
grafts were fixed fully within the infrarenal segment
of the aorta, completely below the lowest renal
artery. Because of the frequent absence of a suitably
long segment of normal infrarenal aorta, the proto-
col and Investigational Device Exemptions were
modified with the FDA to permit transrenal endo-
graft placement. All procedures after the first group
were transrenal.
Endovascular grafts contained within a delivery
catheter were advanced over a 0.038-in Amplatz
super stiff wire to the pararenal segment of the aorta.
A diagnostic catheter was positioned in a similar loca-
tion within the aorta through the opposite common
femoral artery. This diagnostic catheter permitted
dynamic angiography for precise device positioning
(Fig 4). The delivery catheter containing the endo-
graft was retracted caudad, and the endovascular
graft was finally positioned before deployment with-
in the aorta so the gold marker on the graft margin
was aligned with the inferior border of the lowest
renal artery. This position allowed the open portion
of the stent to extend across the orifices of both renal
arteries in all patients in group 2. To insure that
downward migration of the graft would not occur
during balloon deployment, each patient was given
24 mg of adenosine to induce a short (7-second to
10-second) period of asystole before balloon infla-
tion and stent deployment.18 During this asystolic
period, deployment balloon inflation attached the
endograft to the aortic wall with the entire uncov-
ered (porous) portion of the fixation stent positioned
across the renal arteries (Fig 5). Each patient
returned to normal sinus rhythm spontaneously
within 10 seconds after adenosine administration.
Fig 4. Endovascular repair of an abdominal aortic
aneurysm. Endoluminal graft is advanced through the
right common femoral artery to the renal vessels. A diag-
nostic catheter (arrow) is inserted through the contralat-
eral femoral artery and positioned adjacent to the renal
arteries to permit continuous angiography for precise posi-
tioning. After contrast injection through the diagnostic
catheter, the endoluminal graft is positioned precisely at
the site of intended implantation. A gold marker bead on
the margin of the expanded polytetrafluoroethylene graft
(open arrow) is aligned with the inferior border of the low-
est renal artery. 
Fig 3. Introducer catheter system for endoluminal graft insertion. Each endograft is inserted
into the vascular system contained within a specialized delivery sheath (23F). The endolumi-
nal graft is coaxially mounted onto a balloon catheter shaft. This balloon catheter shaft con-
tains a second balloon (arrow), which seals the distal end of the catheter during device inser-
tion and transit through the vascular system. While the tip balloon is inflated, the endoluminal
graft delivery catheter may be pressurized with normal saline to vary its stiffness during pas-
sage through the iliac artery and aorta. 
G, Graft; S, stent; V, valve; I, infusion port.
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Aortic reconstruction and aneurysm exclusion
was completed with an 8 · 80 supporting Wallstent
placed in the tapered segment of the graft to prevent
prosthesis compression or kinking, and an occluding
(covered) Palmaz stent was inserted into the con-
tralateral common iliac artery.19 A femoral-to-
femoral crossover graft was then placed (8 mm
externally supported ePTFE graft, Impra, Tempe,
Ariz) within a standard suprapubic tunnel (Fig 6).
Patient follow-up. Each patient underwent an
angiogram in 2 projections at the completion of the
endovascular grafting procedure. Duplex ultrasound
scan of the aorta, iliac vessels, endograft, and renal
arteries was performed in each patient within 1 week
of the procedure and again at 3, 6, and 12 months.
Annual duplex scan examinations were performed
thereafter. Spiral CT scan of the abdomen and pelvis
performed with intravenous contrast and prepared
with 3 mm section through the visceral segment of
the aorta was performed by 1 week and by 3, 6, and
12 months. Annual studies were performed after 1
year. Magnified views of the renal vessels and
Fig 5. Postdeployment angiogram of an endoluminal graft for repair of an abdominal aortic
aneurysm. A, The uncovered portion of the stent (bound by the small arrows) is completely
below the renal artery orifices (open arrows) in this patient from group 1. B, After transrenal stent
fixation, the uncovered portion of the attachment system (bound by the small arrows) extends
across the renal artery orifices (open arrows). Note the pre-existing left renal artery stenosis.
parenchyma were obtained to look for related disease.
Follow-up angiograms were performed between 3
and 6 months after the procedure in 22 patients (42%
of the total study population). Angiograms were per-
formed in 2 patients for progression of preexisting
infrainguinal ischemia, in 7 patients for iliac limb
compression, in 2 patients to evaluate endoleaks, in 1
patient for evaluation of impotence, and in 10 patients
for graft surveillance. All follow-up angiograms
included a select view of the visceral segment of the
aorta in 2 projections to evaluate the origins of the
renal arteries. The follow-up period for all patients
ranged from 3 to 18 months (mean, 10.3 months;
median, 8 months).
Outpatient follow-up examinations were per-
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formed at 3 weeks, 6 weeks, 3 months, 6 months,
and 12 months and included a physical examination
with an evaluation of blood pressure in both arms
and an analysis of serum creatinine level. Results
were compared with preoperative and immediate
postoperative studies obtained 2 to 3 days after
intervention.
Statistical analysis. A 2-tailed and paired
Student’s t-test and a discriminant analysis were used
to determine significant differences. A value of .05
or less was interpreted as representing a significant
difference.
RESULTS
Fifty-three patients received aortic endografts to
treat AAAs. These patients were divided into 2
groups depending on the implantation site of the
endograft relative to the lowest renal artery. Group
1 patients (n = 16) had their endografts placed com-
pletely below the renal arteries, whereas group 2
patients (n = 37) had the open portion of the fixa-
tion stent placed across the renal vessels. A compar-
ison of AAA size and aortic neck diameter and
length relative to the occurrence of incomplete AAA
exclusion (endoleak) is presented in Table I. There
were no significant differences between groups 1
and 2 with respect to patient demography, AAA size,
or aortic neck length or diameter. Significantly more
proximal aortic endoleaks were seen in group 1 than
in group 2 patients (P < .05).
The median serum creatinine level before endo-
grafting was 1.1 mg/dL (range, 0.7 to 2.2 mg/dL) in
group 1 and 0.9 mg/dL (range, 0.5 to 2.7 mg/dL) in
group 2. After endografting, serum creatinine levels in
both groups did not change significantly, with a medi-
an level of 0.9 mg/dL (range, 0.7 to 1.9 mg/dL) in
group 1 and a median level of 0.7 mg/dL (range, 0.5
to 2.4 mg/dL) in group 2, with the exception of 2
patients who sustained the inadvertent coverage of
their right renal artery by a malpositioned endograft
with the resulting infarction of the respective kidney
(Fig 7). These 2 patients had a rise in serum creatinine
levels after grafting (1.1 mg/dL to 2.4 mg/dL in 1
patient, 0.9 mg/dL to 2.9 mg/dL in the other).
Median blood pressures for group 1 patients and
group 2 patients before and after endografting were
140/80 mm Hg and 135/80 mm Hg, respectively.
No significant change was seen after endograft
placement, nor was there a requirement for addi-
tional antihypertensive medication in any patient
during the follow-up period. Hypertension did not
develop in the 2 patients who had inadvertent sacri-
fice of 1 of their renal arteries.
Fig 6. Schematic drawing of the completed aorto-
femoral-femoral reconstruction for endoluminal repair of
an abdominal aortic aneurysm. An endoluminal anastomo-
sis to the right common femoral artery (arrow) followed by
a femoral-femoral crossover graft completes the contralat-
eral reconstruction. A covered occluding stent is deployed
in the common iliac artery on the left (open arrow) to pre-
vent retrograde flow into the aortic aneurysm. 
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Fig 7. Improper deployment of an endograft for repair of an abdominal aortic aneurysm
demonstrated by means of completion angiogram. A, Preoperative aortogram of a patient with
an abdominal aortic aneurysm. B, Because of the severe aortic neck tortuosity, the precise loca-
tion of the right renal artery was incorrectly identified and covered by the prosthetic endograft.
Arrow, Top of stent; open arrow, edge of graft. 
Table I. Clinical features of patients undergoing endovascular repair of abdominal aortic aneurysm
AAA size Neck diameter Neck length Age 
Group (in mm, mean ± SD) (in mm, mean ± SD)* (in mm, mean ± SD)† (mean ± SD) Sex Proximal endoleak‡
1—Infrarenal placement, 67 ± 6 26 ± 2 19 ± 3 77 ± 6 13 men 38% (6)
n = 16 3 women
2—Transrenal placement, 65 ± 10 26 ± 2 17 ± 5 77 ± 7 33 men 11% (4)
n = 37 4 women
AAA, Abdominal aortic aneurysm; SD, standard deviation of the mean.
*Measured on computed tomography.
†Measured from the lowest renal artery seen in preoperative aortograms.
‡Of the 10 patients without endoleaks, the mean neck length was 19.5 mm. Those with endoleaks had a mean neck length of 17.3 mm
(P = .292).
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No evidence of renal artery stenosis or occlusion
was shown by means of angiographic evaluation of
the aorta after transrenal endograft placement.
Analysis of nephrograms before and after endograft
insertion were unchanged, without evidence of
embolization (Fig 8). An analysis of patients who had
angiographic evidence of renal artery stenosis ( ‡ 50%)
before endografting (n = 18; 34%) did not show
lesion progression after transrenal graft fixation.
Transrenal endografts that showed segmental
parenchymal infarctions within 1 week of grafting
were identified in 2 patients (4%) by means of CT
scan evaluation. In both instances, the infarction
involved less than 20% of the renal parenchyma and
had no observable impact on renal function (Fig 9).
DISCUSSION
Endovascular repair of AAA may represent one
of the most important recent advances in the treat-
ment of this complex problem. Many of the techni-
cal hurdles to achieving a successful endovascular
aortic repair appear to relate to the underlying
anatomy of the aneurysm and amount of residual
normal aortic tissue above and below the lesion.
Although a relatively short proximal and distal aor-
tic neck surrounding an aneurysm can be safely
bridged using conventional vascular graft and suture
techniques, the same limited normal aortic neck
length will severely compromise aortic endograft fix-
ation and the subsequent durability of the repair.
Chuter et al correctly predicted the need for
bifurcated endografts for treating patients with lim-
ited normal distal aortic implantation sites.19
Advances in bifurcated endograft technology have
expectedly expanded the population of patients who
may be offered endograft repairs.20,21
Two potential options are currently available for
managing endograft repair in the patient with a
short proximal or infrarenal aortic neck. The first
option is derived from the concept that, by building
“columnar” strength into the endograft structure,
the force required to keep an endograft properly
positioned within the vessel will be distributed over
the entire length of the graft at its intermittent arte-
rial apposition sites (ie, proximal and distal aortic
neck, iliac arteries, surface of luminal thrombus).22
This is in distinction to single-point endovascular
graft fixation devices that achieve aortic attachment
at focal points, making 1 interface between arterial
wall and endograft the load carrying site.23,24
Columnar supported grafts may, therefore, theoreti-
cally be placed at the base of the lowest renal artery
with very little interposed neck between renal vessel
and aneurysm and continue to maintain their posi-
tion free from migration by the multiple auxiliary
fixation sites.
The second option for achieving durable fixation
of an endograft to the aortic wall when a short
infrarenal neck is present is to extend the site of fix-
ation cephalad, above the renal vessels where the
aortic tissue may be expected to be structurally more
sound compared with that segment immediately
adjacent to the aneurysm. Such transrenal fixation
requires that the endograft and its attachment sys-
tem be designed to permit continued normal perfu-
sion of the visceral vessels, free from flow distur-
bances, obstruction, or distal embolization.
The concept of placing a porous stent across an
arterial side branch is not new. Pan et al25 studied
Fig 9. CT scan performed 3 days after endografting. The
right kidney has a segmental wedge shaped infarct
(arrow).
Fig 8. Delayed image during a follow-up angiogram of a
patient 3 months after endoluminal repair of an abdomi-
nal aortic aneurysm employing a transrenal stent device.
Normal nephrograms without evidence of truncation of
intra-renal or parenchymal vessels are seen. 
S, stent.
the effect of coronary stenting on the patency of side
branches that had been traversed by a stent similar in
design to the one we used. Late side branch occlu-
sion occurred in 9.3% of patients. If an intervention
was subsequently required within the stent-trans-
versed branch vessel, a guide wire could be safely
passed through the interstices of the porous stent,
permitting endovascular intervention of these
“jailed” branches.
Similarly, the Palmaz balloon expandable stent
has been successfully placed across the orifice of the
internal iliac arteries, with preserved vessel paten-
cy.26 Compromised flow to traversed internal iliac
vessels has occasionally been seen and appears to be
related to localized vessel dissection after angioplas-
ty, rather than orificial obstruction by the metallic
strut of a stent.
Recent experience with metallic stents to support
renal artery angioplasty has suggested that the high
volume flow through the renal vessels make them
suitable arteries for prosthetic implants in select sit-
uations.27 Intravascular steel stents fabricated from
316L annealed stainless steel metal may be expected
to interact with blood products to form a relatively
stable thin fibrin layer.28 This newly formed
pseudointima has been shown to permit cellular
ingrowth, with eventual complete endothelial cover-
age of the arterially embedded metal prosthesis.29
Although the anatomic position and arterial inter-
face of intrarenal stents and transrenal aortic stents
are quite different, transrenal stents appear from
early clinical experience to function similarly.12-14
Uncompromisable long-term renal function is an
essential endpoint for successful transrenal fixation of
an endovascular graft. In the present study, the renal
arteries and kidneys were evaluated after intervention
by means of angiographic, ultrasonographic, and CT
data. In addition, serial serum creatinine level deter-
minations were used as a means of analyzing the
functional state of the kidneys after endografting.
Although each of these studies add some under-
standing of the effect of transrenal stenting on renal
artery anatomy and function, they may not be the
ideal analytic tools. True luminal compromise during
follow-up and exact measurements of renal artery
diameter may be more accurately determined by
means of intravascular ultrasonography (IVUS).30
The true vessel wall-to-wall measurements produced
by IVUS images may uncover subtle focal stenoses
induced by an intervention and not seen by means of
other imaging techniques. Such interrogation would
unfortunately require repeated select renal catheteri-
zation and passage of the IVUS catheter through the
stent interstices. Such manipulations themselves may
risk vessel wall injury or distal embolization. These
analyses were not performed in the present study.
Renal artery function after transrenal stenting is
also not ideally analyzed by means of serial serum
creatinine level measurements. Although the mea-
surements are easy to perform, there may be signifi-
cant loss of renal parenchymal tissue because of
embolization and infarction without a significant
change in serum creatinine levels. Renal scintigraphy
may be a more effective technique in identifying
subtle functional loss after manipulation of the renal
vasculature.31 Scintigraphic scans have shown use-
fulness in evaluating the temporal changes in renal
function after renal allograft transplantation and may
be useful after stenting.32 Alternatively, recent work
with magnetic resonance imaging (MRI) has shown
promise for evaluating renal function after interven-
tion.33 Unfortunately, MRI may be limited around a
ferromagnetic stent. These useful imaging methods
were not used in our study population.
The length of normal aortic tissue cephalad to an
infrarenal AAA has an important impact of aortic
endoleak rate and the eventual success of aortic
aneurysm endograft repair.34,35 When grafts and
stents are placed fully below the renal arteries, a
greater length of normal aortic tissue will likely be
needed to achieve a long-term durable seal. In the
10 patients in this study who had proximal
endoleaks, careful analysis of preprocedure and post-
procedure angiograms revealed either a graft posi-
tion too low or insufficient total neck length to cre-
ate and maintain a permanent seal. The length of the
neck may likely help dictate the design and con-
struction of an individual attachment system. The
ideal attachment system construction and shape rel-
ative to the orifice of the renal arteries is unknown.
Further studies of the impact of different endograft
materials and deployment methods (ie, self-expand-
ing or balloon expandable stents) on renal artery
luminal configuration and the risk of distal vessel
embolization will be required before uniform accep-
tance of transrenal endograft fixation in patients who
are at a good risk.
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